pharma · Chronic Hepatitis B · Recurrent Genital Herpes Simplex Type 2 · ASMB
ASSEMBLY BIOSCIENCES
ASSEMBLY BIOSCIENCES, INC.
Assembly Biosciences is a pharma organization headquartered in South San Francisco, USA. It trades on NYSE under ticker ASMB. Primary therapeutic focus areas include Chronic Hepatitis B, Recurrent Genital Herpes Simplex
2 Tower Pl, 7th Floor, South San Francisco, California 94080, US HQ
2014 Founded
99 Employees
Public company Type
ASMB · NYSE Ticker
Company details
- Status
- Public
- HQ
- 2 Tower Pl, 7th Floor, South San Francisco, California 94080, US
- Founded
- 2014
- Employees
- 99
- Programs
- 15
- Drugs
- 10
- Patents
- 14
standard of care (SOC) Nucleoside reverse transcriptase inhibitor (NrtI)
Phase 2 · small molecule · Chronic Hepatitis B
standard of care (SOC) Nucleoside reverse transcriptase inhibitor (NrtI) for Chronic Hepatitis B is a Phase 2 program (small_molecule) at ASSEMBLY BIOSCIENCES, INC. with 1 ClinicalTrials.gov record(s).
Internal code ABI-H0731-211
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- ASSEMBLY BIOSCIENCES, INC.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Chronic Hepatitis B
- Status
- terminated
- Trials
- 1